Mohan Rao, Ph.D.
Dr. Rao is a pharmaceutical economist, entrepreneur, and CEO of Epsilon Life Sciences, with deep expertise in biotech company building and strategic value creation.
David Townson, Ph.D.
Dr. Townson is an executive bringing three decades of oncology and cell therapy leadership from Bayer, Novartis, and Pfizer.
John S. Lollar III, M.D.
Dr. Lollar is a hematologist and Hemophilia of Georgia Professor of Pediatrics at Emory University. He also invented Obizur, a commercialized Factor VIII recombinant.
Kimberly Grove
Ms. Grove has 20+ years of finance & accounting experience at Navigant Consulting, Inc., an NYSE-listed public company, and at Epsilon Life Sciences.
Chris Doering, Ph.D.
Dr. Doering is a Professor of Pediatrics at Emory Medical School, leading drug discovery programs on gene and protein engineering.
Kimberly Nearing
Ms. Nearing has 20+ years of biotech experience in investment banking, venture capital, and senior industry roles at Amgen & IBM Healthcare, driving strategic partnerships and commercial growth.
William Swaney
Mr. Swaney has 25+ years of GMP experience manufacturing 100+ viral vectors and cellular products, including pioneering gene therapies such as CARVYKTI®.